Category: Press Release - Page 16 - Psychedelic Alpha

Read more about the article atai Life Sciences Reports First Quarter 2023 Financial Results and Announces Pipeline Highlights and Updates

atai Life Sciences Reports First Quarter 2023 Financial Results and Announces Pipeline Highlights and Updates

Post published:May 11, 2023
Post category:Press Release

Read more about the article COMPASS Pathways Announces First Quarter 2023 Financial Results and Business Highlights

COMPASS Pathways Announces First Quarter 2023 Financial Results and Business Highlights

Post published:May 11, 2023
Post category:Press Release

Read more about the article MIND CURE CLOSES PREVIOUSLY ANNOUNCED PRIVATE PLACEMENT

MIND CURE CLOSES PREVIOUSLY ANNOUNCED PRIVATE PLACEMENT

Post published:May 11, 2023
Post category:Press Release

Read more about the article Optimi Health Granted Natural Health Product Site Licence By Health Canada

Optimi Health Granted Natural Health Product Site Licence By Health Canada

Post published:May 10, 2023
Post category:Press Release

Read more about the article Clearmind Medicine Retains Crescendo Communications LLC. for Investor Relations and Announces Granting of Stock and Warrants

Clearmind Medicine Retains Crescendo Communications LLC. for Investor Relations and Announces Granting of Stock and Warrants

Post published:May 10, 2023
Post category:Press Release

Read more about the article Terran Biosciences announces publication of PCT patent application covering novel non-hallucinogenic psychoplastogens, including derivatives of DMT and ibogaine with improved pharmacokinetics and engagement at target receptors

Terran Biosciences announces publication of PCT patent application covering novel non-hallucinogenic psychoplastogens, including derivatives of DMT and ibogaine with improved pharmacokinetics and engagement at target receptors

Post published:May 9, 2023
Post category:Press Release

Read more about the article Silo Pharma’s SPC-15 Awarded U.S. Patent Protecting Ongoing R&D of Therapeutic for Stress-Induced Affective Disorder and Alzheimer’s Disease

Silo Pharma’s SPC-15 Awarded U.S. Patent Protecting Ongoing R&D of Therapeutic for Stress-Induced Affective Disorder and Alzheimer’s Disease

Post published:May 9, 2023
Post category:Press Release

Read more about the article Delix Therapeutics Initiates Phase I Trial for Novel Compound DLX-001

Delix Therapeutics Initiates Phase I Trial for Novel Compound DLX-001

Post published:May 9, 2023
Post category:Press Release

Read more about the article FILAMENT HEALTH TO HOST VIRTUAL INVESTOR UPDATE

FILAMENT HEALTH TO HOST VIRTUAL INVESTOR UPDATE

Post published:May 8, 2023
Post category:Press Release

Read more about the article Clearmind Medicine Strengthens Scientific Advisory Board with Appointment of Prof. Joseph Tam

Clearmind Medicine Strengthens Scientific Advisory Board with Appointment of Prof. Joseph Tam

Post published:May 8, 2023
Post category:Press Release

End of content

No more pages to load

Psychedelic Alpha

Psychedelic Alpha is an independent newsletter and community that strives to empower a diverse constellation of individuals and organisations with the knowledge, network and nuance to make an impact within the field of psychedelic medicine and beyond

Quick Links

Newsletter

Insights and interviews delivered to your inbox. No spam, just valuable information.